Skip to main content
SpringerLink
Log in

Medikamentöse Therapie nach gefäßchirurgischen Operationen und endovaskulären Interventionen (S2)

  • Chapter
Leitlinien zu Diagnostik und Therapie in der Gefäßchirurgie

  • 2369 Accesses

Zusammenfassung

Die verwendeten Definitionen entsprechen den Definitionen der American Heart Association [1, 2] und der europäischen Gesellschaft für Kardiologie [3]. Es werden darin Evidenzniveaus und Empfehlungsniveaus definiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. S Silber et al., Guidelines for Percutaneous Coronary Interventions. The Force for Percutaneous interventions of the European Society of Cardiology. Eur Heart J (2005), 26, 804–847

    Article  PubMed  Google Scholar 

  2. Smith SC et al., AHA/ ACC Guidelines for secondary prevention for patients with coeronary and other atherosclerotic vascular disease: 2006 update. Circulation (2006), 113, 2363–2372

    Article  PubMed  Google Scholar 

  3. Hirsh AT et al., AHA/ACC Guidlines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Am Coll Cardiology (2006), 47, 1–192

    Article  Google Scholar 

  4. Diener HC, Putzki N, Berlit P: Leitlinien für Diagnostik und Therapie in der Neurologie, (2005) 3. überarb. Aufl., Georg Thieme, Stuttgart, New York

    Google Scholar 

  5. Poldermans D, Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group, The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med (1999), 341(24), 1789–1794

    Article  CAS  PubMed  Google Scholar 

  6. Mangano DT, Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med (1996), 335(23), 1713–1720

    Article  CAS  PubMed  Google Scholar 

  7. Kertai MD et al., A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg (2004), 28, 343–352

    Article  CAS  PubMed  Google Scholar 

  8. Durazzo AE et al., Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg (2004), 39, 967–975

    Article  PubMed  Google Scholar 

  9. H Mudra et al., Positionspapier zur Indikation und Durchführung der interventionellen Behandlung extrakranieller Karotisstenosen. VASA (2006), 35, 125–131

    Article  CAS  PubMed  Google Scholar 

  10. Engelter S, Lyrer P, Antiplatelet therapy for preventing stroke and other vascular events after carotid endarteriectomy. Cochrane Database Syst Rev 2003 (3): CD001458

    Google Scholar 

  11. Schillinger M et al., Balloon Angioplasty versus Nitino stents in the superficial femoral artery. N Engl J Med (2006), 354, 1879–1888

    Article  CAS  PubMed  Google Scholar 

  12. Strecker EPK et al., Clopidogrel plus long-term aspirin after femoro-popliteal stenting.The Calfs project: 1-and 2-year results. Eur Radiol (2004), 14, 302–308

    Article  PubMed  Google Scholar 

  13. Doerffler-Melly J et al., Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev (2005), CD002071

    Google Scholar 

  14. The Dutch Bypass Oral anticoagulants or aspirin (BOA) Study Group, Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet (2000), 355, 346–351

    Article  Google Scholar 

  15. Amendt K, Antikoagulation oder Antiaggregation in der Bypasschirurgie bei arterieller Verschlusskrankheit der Beine (pAVK). Gefässchirurgie (2007), 12, 63–72

    Article  Google Scholar 

  16. Doerffler-Melly J et al., Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev (2003), Issue 4, CD000536

    Google Scholar 

  17. Johnson WC, Williford WO, Benefits, morbidity and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral artereial bypass procedures: a prospective randomides study. J Vasc Surg (2002), 35, 362–368

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Deutsche Gesellschaft für Gefäßchirurgie

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2010 Springer Medizin Verlag Heidelberg

    About this chapter

    Cite this chapter

    Deutsche Gesellschaft für Gefäßchirurgie. (2010). Medikamentöse Therapie nach gefäßchirurgischen Operationen und endovaskulären Interventionen (S2). In: Leitlinien zu Diagnostik und Therapie in der Gefäßchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04710-7_19

    Download citation

    • DOI: https://doi.org/10.1007/978-3-642-04710-7_19

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-642-04709-1

    • Online ISBN: 978-3-642-04710-7

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation